Merit Medical Announced FDA Approval of the WRAPSODY Cell-Impermeable Endoprosthesis
On December 20, 2024, Merit Medical Systems, Inc., a leading global manufacturer and marketer of advanced healthcare technologies, announced that its WRAPSODY® Cell-Impermeable Endoprosthesis received premarket approval (PMA) from the U.S. Food and Drug Administration (FDA).
“Preserving vascular access for dialysis patients is critical for them to maintain lifesaving treatment,” said Dr. Dolmatch, credited as co-inventor of the WRAPSODY device. “I believe the advancements that the WRAPSODY device offers will translate to better outcomes for hemodialysis patients.”
The W...
